LivBody vs MEDVi: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated August 14, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Short answer: MEDVi scores higher on our rubric, 5.7/10 against 2.9/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit MEDVi - our pick of these two →or find your match

MEDVi beats LivBody overall, scoring 5.7/10 vs 2.9/10. Published pricing is not a like-for-like monthly comparison: LivBody is from $179/mo; MEDVi is $179 first month, then $299/mo. Choose LivBody for followers of the livbody supplement brand who specifically want compounded glp-1 injections tied to a name they already know, and who will confirm the real monthly price at checkout before paying. Choose MEDVi for users who want both oral and injectable compounded options in one telehealth program.

A side-by-side look at LivBody and MEDVi to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

LivBody

#54 of 54

2.9/10

GLP-1 telehealth program from LivBody, the fitness-influencer supplement brand founded by Paige Hathaway in 2018 (legal entity LivBody HoldCo LLC). The GLP-1 arm launched around early 2026 and is an OpenLoop white-label: clinicians come from OpenLoop Healthcare Partners, PC (the terms also use the name 'LivBody Healthcare Partners, PC'), the listed Des Moines, IA headquarters is OpenLoop's office, and cancellations go through an OpenLoop support desk. Sells compounded semaglutide and compounded tirzepatide as weekly injections, with the consult and free expedited overnight shipping included in the monthly price. Prescriptions are filled by four named compounding pharmacies: RedRock Pharmacy (UT), Health Warehouse (KY), Precision Compounding (NY), and Triad Rx (AL).

Visit LivBody

Higher Rated

MEDVi

#46 of 54

5.7/10

MEDVi offers oral and injectable compounded GLP-1 care. Semaglutide is $179 for month one and $299 for refills. Trustpilot is 4.4/5 across roughly 11,000 reviews, while BBB is F/not accredited. FDA warning letter #721455 concerns misleading labeling and marketing, not an allegation that the medication was unsafe.

Visit MEDVi

Feature	LivBody	MEDVi
Our Score	2.9/10	5.7/10
Headline Price	from $179/mo	$179 first month, then $299/mo
Medication Type	Compounded	Both
Insurance Accepted	No	No
Best For	Followers of the LivBody supplement brand who specifically want compounded GLP-1 injections tied to a name they already know, and who will confirm the real monthly price at checkout before paying	Users who want both oral and injectable compounded options in one telehealth program
Watch out for	Pricing contradicts itself on the SAME page: landing cards say 'Starting at $179'/mo semaglutide and $279/mo tirzepatide, but the FAQ says the program 'starts at just $249/month'. Checkout is captcha-gated, so we could not resolve which number is real, confirm the actual price at checkout before paying	FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
Ranking	#54	#46
Get started	Visit LivBody	Visit MEDVi

Pros & Cons Compared

LivBody

Pros

+Four compounding pharmacies named WITH street addresses, RedRock Pharmacy (UT), Health Warehouse (KY), Precision Compounding (NY), and Triad Rx (AL), more pharmacy transparency than most competitors offer
+Named medical group, OpenLoop Healthcare Partners, PC, most white-label storefronts name no one
+Consult and shipping included in the monthly price ('no hidden fees'), with free expedited overnight shipping
+Real 8-year-old brand with a named founder, Paige Hathaway founded LivBody in 2018, this is not an anonymous pop-up storefront
+Proper compounded-medication disclosures, the site states plainly that compounded GLP-1s are not FDA-approved
+Available in all 50 states plus DC (terms hedge that 'some services may not be available in all states')

Cons

−Pricing contradicts itself on the SAME page: landing cards say 'Starting at $179'/mo semaglutide and $279/mo tirzepatide, but the FAQ says the program 'starts at just $249/month'. Checkout is captcha-gated, so we could not resolve which number is real, confirm the actual price at checkout before paying
−Terms state ALL FEES NON-REFUNDABLE (in all-caps), which contradicts an undefined 'LIV Body guarantee' badge on the landing page
−The GLP-1 program is an OpenLoop white-label: clinicians are OpenLoop Healthcare Partners, PC, the listed Des Moines HQ is OpenLoop's office, and the cancellation desk is an OpenLoop zohodesk email. The LivBody supplement brand is not the one treating you
−Zero independent GLP-1 track record: Trustpilot shows 0 reviews (profile claimed February 2026), and the BBB rates the supplement entity (Liv Body LLC, Henderson NV) B-, not accredited, with an unanswered complaint
−Supplement-product testimonials are recycled onto the GLP-1 page as patient social proof
−Pharmacy partner Triad Rx (AL) received a 2019 FDA warning letter for sterile-production violations; the FDA closed it out in May 2023, we state both facts because both matter
−Broken legal links: the Medical Consent and Patient Bill of Rights documents point to start.livbody.com, a domain that does not resolve
−No named medical director, no labs, no video-visit path, no clinical infrastructure disclosed beyond the OpenLoop group name
−Injectables only, no oral or sublingual option, no microdose tier, no brand-name access, and no LegitScript certification found (the site links only the LegitScript checker)

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179 covers the first month of compounded semaglutide on the current Katalys landing, including clinician review, medication and shipping

Cons

−FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
−Its third-party records conflict: 4.4/5 across roughly 11,000 Trustpilot reviews, but an F and no accreditation at the BBB
−The $179 semaglutide price is introductory; the current Katalys landing says refills are $299/mo, making the first-year total $3,468 rather than $2,148
−Brand-name Wegovy and Zepbound paths add a $99 membership plus the medication cost, which the current landing does not publish; availability can change
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

Our Verdict

MEDVi edges out LivBody with a score of 5.7/10 vs 2.9/10. Published pricing is not a like-for-like monthly comparison: LivBody is from $179/mo; MEDVi is $179 first month, then $299/mo. MEDVi offers both brand-name and compounded medications, giving you more flexibility.